Yu B - Search Results

1

Three-year clinical outcomes of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: A prospective patient-level pooled analysis of NeoVas trials.

Wang X, Li Y, Fu G, Xu B, Zhou Y, Su X, Liu H, Zhang Z, Yu B, Tao L, Zheng Q, Li L, Xu K, Han Y; NeoVas OPC Investigators. Wang X, et al. Among authors: yu b. Catheter Cardiovasc Interv. 2023 May;101(6):967-972. doi: 10.1002/ccd.30518. Epub 2023 Mar 7. Catheter Cardiovasc Interv. 2023. PMID: 36881746

2

PLATINUM China: a prospective, randomized investigation of the platinum chromium everolimus-eluting stent in de novo coronary artery lesions.

Gao R, Han Y, Yang Y, Zhang J, Hou Y, Wang H, Li H, Fang Q, Yu B, Xu B, Allocco DJ, Dawkins KD. Gao R, et al. Among authors: yu b. Catheter Cardiovasc Interv. 2015 Mar;85 Suppl 1:716-23. doi: 10.1002/ccd.25859. Epub 2015 Feb 18. Catheter Cardiovasc Interv. 2015. PMID: 25631909 Clinical Trial.

3

Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial.

Gao R, Yang Y, Han Y, Huo Y, Chen J, Yu B, Su X, Li L, Kuo HC, Ying SW, Cheong WF, Zhang Y, Su X, Xu B, Popma JJ, Stone GW; ABSORB China Investigators. Gao R, et al. Among authors: yu b. J Am Coll Cardiol. 2015 Dec 1;66(21):2298-2309. doi: 10.1016/j.jacc.2015.09.054. Epub 2015 Oct 12. J Am Coll Cardiol. 2015. PMID: 26471805 Free article. Clinical Trial.

4

Tert-butylhydroquinone attenuates the ethanol-induced apoptosis of and activates the Nrf2 antioxidant defense pathway in H9c2 cardiomyocytes.

Shi X, Li Y, Hu J, Yu B. Shi X, et al. Among authors: yu b. Int J Mol Med. 2016 Jul;38(1):123-30. doi: 10.3892/ijmm.2016.2605. Epub 2016 May 25. Int J Mol Med. 2016. PMID: 27220726 Free PMC article.

5

Plaque erosion delays vascular healing after drug eluting stent implantation in patients with acute coronary syndrome: An In Vivo Optical Coherence Tomography Study.

Hu S, Wang C, Zhe C, Zhu Y, Yonetsu T, Jia H, Hou J, Zhang S, Jang IK, Yu B. Hu S, et al. Among authors: yu b. Catheter Cardiovasc Interv. 2017 Mar;89(S1):592-600. doi: 10.1002/ccd.26943. Catheter Cardiovasc Interv. 2017. PMID: 28318137

6

Chronic total occlusion is associated with a higher incidence of malapposition and uncovered stent struts: OCT findings at 6 months following DES implantation.

Jia H, Hu S, Liu H, Zhu Y, Zhe CY, Li L, Mustafina I, Hou J, Zhang S, Yu B. Jia H, et al. Among authors: yu b. Catheter Cardiovasc Interv. 2017 Mar;89(S1):582-591. doi: 10.1002/ccd.26969. Catheter Cardiovasc Interv. 2017. PMID: 28318139

7

Percutaneous Left Atrial Appendage Closure With the LAmbre Device for Stroke Prevention in Atrial Fibrillation: A Prospective, Multicenter Clinical Study.

Huang H, Liu Y, Xu Y, Wang Z, Li Y, Cao K, Zhang S, Yang Y, Yang X, Huang D, Yu B, Su X, Wu L, Huang C. Huang H, et al. Among authors: yu b. JACC Cardiovasc Interv. 2017 Nov 13;10(21):2188-2194. doi: 10.1016/j.jcin.2017.06.072. JACC Cardiovasc Interv. 2017. PMID: 29122133 Free article.

8

The Refinement of Risk Stratification for Atrial Thrombus or Spontaneous Echo Contrast in Nonvalvular Atrial Fibrillation.

Ning W, Li Y, Ma C, Qiu L, Yu B. Ning W, et al. Among authors: yu b. Int Heart J. 2017 Dec 12;58(6):885-893. doi: 10.1536/ihj.16-444. Epub 2017 Nov 17. Int Heart J. 2017. PMID: 29151480 Free article.

9

Chinese expert consensus on the non-invasive imaging examination pathways of stable coronary artery disease.

Chen YD, Fang WY, Chen JY, Fan ZM, Gao CY, Ge JB, He ZX, Huo Y, Li L, Li SJ, Lu XL, Lv B, Qian JY, Shi YJ, Shen ZJ, Wang J, Wang YN, Xu L, Yang L, Yu B, Zhang M, Yang JJ, Zhang SY, Zhang XL, Zhao SH, Zheng Y, Han YC, Zhi G. Chen YD, et al. Among authors: yu b. J Geriatr Cardiol. 2018 Jan;15(1):30-40. doi: 10.11909/j.issn.1671-5411.2018.01.012. J Geriatr Cardiol. 2018. PMID: 29434623 Free PMC article. No abstract available.

10

Safety and efficacy of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: One-year results from a prospective patient-level pooled analysis of NeoVas trials.

Xu K, Fu G, Xu B, Zhou Y, Su X, Liu H, Zhang Z, Yu B, Wang X, Han Y; NeoVas OPC Investigators. Xu K, et al. Among authors: yu b. Catheter Cardiovasc Interv. 2019 Feb 15;93(S1):832-838. doi: 10.1002/ccd.28067. Catheter Cardiovasc Interv. 2019. PMID: 30888736

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,662 results

Search Page